Copertina

Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ann I. Scher, Xiyun Chai, Kirk W. Johnson
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”
di: Gabriel Gárate, et al.
Pubblicazione: (2024)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
di: Irina Krikova, et al.
Pubblicazione: (2024)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
di: Andrea M. Kuczynski, et al.
Pubblicazione: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
di: Kara S. Graves, et al.
Pubblicazione: (2026)

Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene‐related peptide sensitization
di: Eric A. Kaiser, et al.
Pubblicazione: (2025)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
di: Samuel K. Peasah, et al.
Pubblicazione: (2024)

Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists
di: Zoe Tasma, et al.
Pubblicazione: (2025)

Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors
di: Alex Harlan, et al.
Pubblicazione: (2025)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
di: Anna de Dios, et al.
Pubblicazione: (2024)

Arterial hypertension: A safety risk of calcitonin gene‐related peptide ligand and receptor blocker class
di: David Croteau, et al.
Pubblicazione: (2026)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
di: Alba López‐Bravo, et al.
Pubblicazione: (2025)

American Headache Society white paper on treatment of post‐traumatic headache from concussion in youth
di: Carlyn Patterson Gentile, et al.
Pubblicazione: (2024)

Transcutaneous electrical nerve stimulation of the occipital nerves as treatment for chronic cluster headache
di: Ida Stisen Fogh‐Andersen, et al.
Pubblicazione: (2024)

Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report
di: Yunzhu Tang, et al.
Pubblicazione: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
di: Joaquín Borrás‐Blasco, et al.
Pubblicazione: (2025)

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure
di: Tzu‐Hsuan Su, et al.
Pubblicazione: (2024)

Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
di: Marta Pascual‐Mato, et al.
Pubblicazione: (2024)

Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
di: Jennifer Robblee, et al.
Pubblicazione: (2024)

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
di: Genaro G. Gutierrez, et al.
Pubblicazione: (2025)

Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache
di: Roemer B. Brandt, et al.
Pubblicazione: (2025)

Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays
di: Michael L. Garelja, et al.
Pubblicazione: (2025)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
di: Alexander Yoo, et al.
Pubblicazione: (2025)

Response to: Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays
di: Alicia Alpuente, et al.
Pubblicazione: (2026)

Beneficial effect of infiltration around the greater occipital nerve in cluster headache independent of modulation of the nociceptive blink reflex
di: Willemijn C. Naber, et al.
Pubblicazione: (2025)

Comfort matters: A new strategy to ease injection pain during headache treatment procedures
di: Hannah F. J. Shapiro
Pubblicazione: (2026)

Cluster headache vs. labor: A comparative perspective on acute pain during and after delivery
di: Joudi Sharaf, et al.
Pubblicazione: (2025)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
di: Brooke L. Reidy, et al.
Pubblicazione: (2025)

Temporary occipital nerve stimulation as transitional therapy for chronic intractable cluster headache: A case report and proof of concept
di: Keshet Pardo, et al.
Pubblicazione: (2026)

Greater occipital nerve block for chronic headache management in children and adolescents: A longitudinal observational study and systematic review
di: Maria Morozova, et al.
Pubblicazione: (2025)

Response to Letter to the Editor regarding “Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays”
di: Michael L. Garelja, et al.
Pubblicazione: (2026)

The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model
di: Janosch Fox, et al.
Pubblicazione: (2024)

The clinical effect of an implanted vagus nerve stimulator in a patient with chronic cluster headache and focal epilepsy – A case report
di: Paulien J. van Tilborg, et al.
Pubblicazione: (2025)

Today in headache medicine: Helpful analogies in headache medicine
di: Medha Tandon, et al.
Pubblicazione: (2025)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
di: Christopher C. Anderson, et al.
Pubblicazione: (2024)

Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study
di: Heiko Pohl, et al.
Pubblicazione: (2024)

Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure
di: Dean Zeldich, et al.
Pubblicazione: (2025)

Identifying and predicting headache trajectories among those with acute post‐traumatic headache
di: Lingchao Mao, et al.
Pubblicazione: (2025)

The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
di: Dani C. Smith, et al.
Pubblicazione: (2024)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
di: Raghavan Gopalakrishnan, et al.
Pubblicazione: (2024)

Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity
di: Rehab Magdy, et al.
Pubblicazione: (2025)